Patients with known cardiovascular disease who have not had a recent acute event are
often referred to as having stable coronary artery disease (CAD). The concept of 'stable'CAD …

Even two centuries after they were first described, atherosclerosis and atherothrombosis
remain among the leading causes of death worldwide. Over the last decades it has become …

The pathophysiology of atherosclerosis involves a diseased endothelium, lipid accumulation
and low-grade inflammation. In later stages of coronary artery disease (CAD) and peripheral …

Patients with peripheral artery disease (PAD) are at a high risk not only for the classical
cardiovascular (CV) outcomes (major adverse cardiovascular events; MACE) but also for …

Patients with acute coronary syndrome (ACS) require long-term antithrombotic intervention
to reduce the risk of further ischemic events; dual antiplatelet therapy with a P2Y 12 inhibitor …

Background: Acute coronary syndromes (ACS) represent the final step in the chronic
process of atherothrombotic coronary disease which begins early in life as thickening of …

Purpose Dual antiplatelet therapy (DAPT) with aspirin and a P2Y 12 inhibitor is currently
recommended to prevent further ischemic events after percutaneous coronary intervention …

Trotz intensiver wissenschaftlicher Untersuchungen in den vergangenen Jahrzehnten
stellen atheroskleroseassoziierte Erkrankungen die häufigste Todesursache weltweit dar. In …

The myth of ‘stable’ coronary artery disease Page 1 The myth of ‘stable’ coronary artery
disease Keith AA Fox1 Marco Metra,2 João Morais3 and Dan Atar4 Affiliations 1British …

Ziel: Unter diesem Konsens ist das Ziel dieser retrospektiven, monozentrischen Studie,
Transfusions-und Blutungsrisiko sowie die perioperative Morbidität und Mortalität unter …